2 top experts resigned from a key panel after the FDA approved a new Alzheimer's drug

Retrieved on: 2021-06-10 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

2 top experts resigned from a key panel after the FDA approved a new Alzheimer's drug. View article details on hiswai:

Excerpt

Two top neuroscience experts resigned this week from a committee that advises the FDA. The doctors stepped down after the agency approved a ...

Article found on: www.businessinsider.com